Spondyloarthritis

In patients with spondyloarthritis, genetics and disease activity levels likely impact the composition of gut microbiota, according to data published in Arthritis & Rheumatology.

Most patients with immune-mediated inflammatory diseases who had weakened responses to a standard vaccine series for COVID-19 mounted a serological response to a third dose, according to data published in Arthritis and Rheumatology.

More than half of a cohort of patients with rheumatic or musculoskeletal diseases reported experiencing some post-traumatic stress outcomes during the COVID-19 pandemic, according to data presented at the EULAR 2022 Congress.

Nurse-led education for patients with rheumatoid arthritis or spondyloarthritis, who are beginning biologic disease-modifying antirheumatic drugs, is effective at changing behaviors to prevent adverse events, according to data.

Acute anterior uveitis in first-degree relatives of axial spondyloarthritis probands should trigger a screening for axial SpA, according to researchers in the Annals of the Rheumatic Diseases.

Children with spondyloarthritis and polyarticular arthritis demonstrate greater internalized disturbances and worse psychological functioning in school and social arenas, according to data.

While there is a cross-section of drugs that are FDA-approved for the treatment of axial spondyloarthritis, clinicians and researchers continue to struggle with axial psoriatic arthritis, according to a presenter at ACR Convergence 2021.

Physical activity can lead to improved quality of life and self-reported function in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis, according to data published in Arthritis Care & Research.

Treat-to-target tapering of TNF inhibitors in patients with psoriatic arthritis or axial spondyloarthritis does not result in any negative impact on disease activity, compared with the full dose, according to data published in Rheumatology.

Sex and gender differences between patients with psoriatic arthritis and axial spondyloarthritis may explain why women experience longer diagnostic delays, higher burden and lower drug survival in these diseases, noted a speaker here.